<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Boehringer Ingelheim ceases production of Trodax flukicide</title><link>/b/veterinary-news/posts/boehringer-ingelheim-ceases-production-of-trodax-flukicide</link><description> Boehringer Ingelheim Animal Health has announced that it has ceased production of the flukicide product Trodax 34% w/v Solution for Injection, containing nitroxynil, for the European market. 
 Trodax is used to treat the mature and late-immature stages</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>